News & Media
Dr. Di Zhao Named an AACR Annual Meeting 2025 NextGen Star
Dr. Di Zhao has been recognized as a NextGen Star for the AACR Annual Meeting 2025, a prestigious honor that highlights her significant contributions to cancer research.
Interview with UroToday
Dr. Zhao was recently interviewed by UroToday to discuss her team’s published research on “Immune checkpoint B7-H3 as a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.”
Highlighted in UroToday
UroToday also featured Dr. Zhao's recent publication in Science Translational Medicine, emphasizing the impact of the lab's work in advancing cancer therapies.
MD Anderson News Releases
The Zhao Lab’s research has been featured in multiple MD Anderson news releases:
MD Anderson Research Highlights for May 10, 2023
MD Anderson Research Highlights for July 13, 2022